[go: up one dir, main page]

NO20074100L - Mikroimplantater for okulaer administrering - Google Patents

Mikroimplantater for okulaer administrering

Info

Publication number
NO20074100L
NO20074100L NO20074100A NO20074100A NO20074100L NO 20074100 L NO20074100 L NO 20074100L NO 20074100 A NO20074100 A NO 20074100A NO 20074100 A NO20074100 A NO 20074100A NO 20074100 L NO20074100 L NO 20074100L
Authority
NO
Norway
Prior art keywords
microplants
implants
ocular administration
methods
microns
Prior art date
Application number
NO20074100A
Other languages
English (en)
Other versions
NO339496B1 (no
Inventor
Thierry Nivaggioli
David A Weber
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20074100L publication Critical patent/NO20074100L/no
Publication of NO339496B1 publication Critical patent/NO339496B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives implantater og mikroimplantater som omfatter homogene blandinger av et virkestoff og en bionedbrytbar polymerer, som inkluderer mikroimplantater som har diametere på 483 ?m eller mindre og som kan avleveres til øyet ved bruk av selvforseglende metoder. Videre beskrives fremgangsmåter for fremstilling av implantatene og mikroimplantatene som fører til partier av høyt ensartede implantater og mikroimplantater innenfor meget snevre toleranseområder.
NO20074100A 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering NO339496B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/070,158 US20060204548A1 (en) 2005-03-01 2005-03-01 Microimplants for ocular administration
PCT/US2006/006279 WO2006093758A1 (en) 2005-03-01 2006-02-22 Microimplants for ocular administration

Publications (2)

Publication Number Publication Date
NO20074100L true NO20074100L (no) 2007-11-23
NO339496B1 NO339496B1 (no) 2016-12-19

Family

ID=36579748

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074100A NO339496B1 (no) 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering

Country Status (17)

Country Link
US (1) US20060204548A1 (no)
EP (2) EP1863420B1 (no)
JP (2) JP2008531687A (no)
KR (1) KR101271362B1 (no)
CN (1) CN101188989B (no)
AU (1) AU2006218931B2 (no)
BR (1) BRPI0607483A2 (no)
CA (1) CA2598512C (no)
ES (1) ES2678401T3 (no)
IL (1) IL185250A0 (no)
MX (1) MX2007010305A (no)
NO (1) NO339496B1 (no)
NZ (2) NZ588831A (no)
RU (1) RU2357709C1 (no)
TR (1) TR201810174T4 (no)
WO (1) WO2006093758A1 (no)
ZA (1) ZA200706622B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU3649502A (en) 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
AU2005314426A1 (en) * 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
JP5694664B2 (ja) * 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
AU2008310956B2 (en) 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
AU2010259184B2 (en) 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
CN103917202B (zh) * 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 眼插入件装置和方法
RU2494775C1 (ru) * 2012-06-21 2013-10-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения люэтической оптической нейропатии
RU2627639C2 (ru) * 2012-06-29 2017-08-09 Джонсон Энд Джонсон Вижн Кэа, Инк. Способ и офтальмологическое устройство гальванического лечения глаз
WO2014066775A1 (en) 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
WO2014159060A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
RU2557925C1 (ru) * 2014-03-17 2015-07-27 Новиков Сергей Викторович Биодеградируемый многослойный имплант для введения лекарственных веществ в витреальную полость глаза
WO2016168141A1 (en) 2015-04-13 2016-10-20 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
TWI799366B (zh) 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
RU2763916C2 (ru) 2015-09-23 2022-01-11 Дженентек, Инк. Оптимизированные варианты анти-vegf антител
CA3042009C (en) * 2016-10-28 2020-05-19 SpineThera Pharmaceutical compositions and uses thereof
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
CN107595765A (zh) 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
EP4171544A4 (en) * 2020-06-26 2024-07-24 Purdue Research Foundation PHARMACEUTICAL FORMULATIONS OF GRISEOFULVINE FOR LONG-TERM EYE ADMINISTRATION
EP4444273A4 (en) * 2021-12-06 2025-11-26 Ocular Therapeutix Inc EXTRUDED OCULAR INSERTS OR IMPLANTS AND ASSOCIATED PROCESSES
US11883561B1 (en) * 2022-10-21 2024-01-30 Reselute, Inc. Drug eluting implants and methods for producing the same

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58126435U (ja) * 1982-02-19 1983-08-27 オリンパス光学工業株式会社 Ｔｔｌオ−トストロボ用絞り制御回路
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US6855331B2 (en) * 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
RU2120254C1 (ru) * 1997-10-28 1998-10-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Имплантат для реконструктивно-восстановительной хирургии
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU3649502A (en) * 2000-11-29 2002-06-11 Oculex Pharm Inc Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
JP5105697B2 (ja) * 2002-01-18 2012-12-26 シヴィダ・インコーポレイテッド コドラッグのコントロールデリバリ用ポリマー性ゲルシステム
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20040137059A1 (en) * 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process

Also Published As

Publication number Publication date
WO2006093758A1 (en) 2006-09-08
NZ588831A (en) 2012-05-25
MX2007010305A (es) 2007-09-27
CA2598512C (en) 2018-08-14
ZA200706622B (en) 2008-09-25
EP1863420A1 (en) 2007-12-12
RU2007132699A (ru) 2009-04-10
JP2008531687A (ja) 2008-08-14
BRPI0607483A2 (pt) 2009-09-08
KR101271362B1 (ko) 2013-06-10
NZ560397A (en) 2010-11-26
CN101188989A (zh) 2008-05-28
TR201810174T4 (tr) 2018-08-27
KR20070116030A (ko) 2007-12-06
ES2678401T3 (es) 2018-08-10
IL185250A0 (en) 2008-02-09
JP2013067644A (ja) 2013-04-18
CN101188989B (zh) 2010-06-23
RU2357709C1 (ru) 2009-06-10
NO339496B1 (no) 2016-12-19
EP2364680A1 (en) 2011-09-14
AU2006218931A1 (en) 2006-09-08
CA2598512A1 (en) 2006-09-08
US20060204548A1 (en) 2006-09-14
AU2006218931B2 (en) 2011-07-14
EP1863420B1 (en) 2018-04-18

Similar Documents

Publication Publication Date Title
NO20074100L (no) Mikroimplantater for okulaer administrering
EP4596041A3 (en) Farnesoid x receptor agonists and uses thereof
EP4445954A3 (en) Cellular models of and therapies for ocular diseases
EP3050876A3 (en) Kinase modulators
EP4545070A3 (en) Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
BR0214992A (pt) Artigo microfibrilado hidrofìlico, e, método para preparar o mesmo
WO2006132647A3 (en) Antimicrobial copolymers and uses thereof
BRPI0506983A (pt) composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
WO2006081172A3 (en) Compounds and compositions as protein kinase inhibitors
EP2407171A3 (en) Compositions and methods for the treatment of ophthalmic disease
WO2007030266A3 (en) Nitric oxide-releasing polymers derived from modified polyimines
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ATE530142T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
EP1825948A3 (en) Nozzle for laser net shape manufacturing
WO2013158814A8 (en) Immediate release, abuse deterrent pharmaceutical compositions
EP4338802A3 (en) Tyk2 inhibitors, uses, and methods for production thereof
WO2008109347A3 (en) Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles
WO2004039248A3 (en) Repairing or replacing tissues or organs
BR112012027590A2 (pt) conjugado de fator viii de coagulação sanguínea
MX2023003556A (es) Composiciones farmaceuticas.
WO2019055996A8 (en) Polymer nanodiscs for biotechnology and medical applications
NO20065763L (no) Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention
BR112014006608A2 (pt) formulações com base em dispersões sólidas
BRPI0411752A (pt) implantes subcutáneos apresentando liberação inicial limitada do princìpio ativo e liberação ampliada subseqüente linearmente variável do mesmo